(Q46866619)

English

A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d'Ivoire

scientific article published on 31 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d'Ivoire (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

0 references

0 references

object named as

Pierre Chauvin

10

0 references

Bradford D Gessner

9

object named as

Bradford D Gessner

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

Karl-Heinz Herbinger

2

object named as

Karl-Heinz Herbinger

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

author name string

Daniel Ekra

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

Seydou Konate

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

Annie Leblond

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

Catherine Fretz

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

Vannina Cilote

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

Caroline Douai

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

Alfred Da Silva

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

language of work or name

0 references

publication date

31 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

26

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

22

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

2753-2761

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Infection of the fetus with hepatitis B e antigen via the placenta

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

HBeAg and anti-hbe detection by radioimmunoassay: Correlation with vertical transmission of hepatitis B virus in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

The e antigen and vertical transmission of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

A 5-year immunization field trial against hepatitis B using a Chinese hamster ovary cell recombinant vaccine in French Polynesian newborns: results at 3 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Persistence of specific antibodies after hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Twelve-year follow-up study of hepatitis B immunization of Senegalese infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Clinical practice: prevention of hepatitis B with the hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Impaired response to recombinant hepatitis B vaccine in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.018

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.03.018

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18436354

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46866619&oldid=2135317497"